Target N V Biotech Molecular Templates, Inc. (MTEM) insider trading activity

Target N V Biotech is of Molecular Templates, Inc.. Currently has a direct ownership of 1.28 Million shares of MTEM, which is worth approximately $2 Million. The most recent transaction as insider was on Apr 02, 2024, when has been sold 250,000 shares (Common Stock) at a price of $2.35 per share, resulting in proceeds of $587,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.28M

0% 3M change

91.71% 12M change

Total Value Held $2 Million

TARGET N V BIOTECH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 02 2024	BUY Open market or private purchase	$587,500 $2.35 p/Share	250,000 Added 16.34%	1,279,820 Common Stock
Jul 17 2023	BUY Open market or private purchase	$1,999,999 $0.47 p/Share	4,255,319 Added 21.6%	15,447,322 Common Stock
May 16 2022	BUY Open market or private purchase	$236,000 $1.18 p/Share	200,000 Added 1.76%	11,192,003 Common Stock
Jan 06 2022	BUY Open market or private purchase	$808,000 $4.04 p/Share	200,000 Added 1.79%	10,992,003 Common Stock
Sep 21 2021	BUY Open market or private purchase	$4,500,000 $6.0 p/Share	750,000 Added 6.5%	10,792,003 Common Stock
Sep 16 2021	BUY Open market or private purchase	$613,000 $6.13 p/Share	100,000 Added 0.99%	10,042,003 Common Stock
Jul 27 2021	BUY Open market or private purchase	$531,750 $7.09 p/Share	75,000 Added 0.75%	9,942,003 Common Stock
Jul 26 2021	BUY Open market or private purchase	$560,000 $7.0 p/Share	80,000 Added 0.8%	9,867,003 Common Stock
Jul 20 2021	BUY Open market or private purchase	$891,250 $7.13 p/Share	125,000 Added 1.26%	9,787,003 Common Stock
Jul 19 2021	BUY Open market or private purchase	$830,899 $6.96 p/Share	119,382 Added 1.22%	9,662,003 Common Stock
Apr 19 2021	BUY Open market or private purchase	$330,084 $8.08 p/Share	40,852 Added 0.43%	9,542,621 Common Stock
Apr 15 2021	BUY Open market or private purchase	$1,293,000 $8.62 p/Share	150,000 Added 1.55%	9,501,769 Common Stock
Apr 14 2021	BUY Open market or private purchase	$1,255,500 $8.37 p/Share	150,000 Added 1.58%	9,351,769 Common Stock
Apr 13 2021	BUY Open market or private purchase	$781,000 $7.81 p/Share	100,000 Added 1.08%	9,201,769 Common Stock
Apr 12 2021	BUY Open market or private purchase	$401,000 $8.02 p/Share	50,000 Added 0.55%	9,101,769 Common Stock
Apr 09 2021	BUY Open market or private purchase	$1,939,515 $8.23 p/Share	235,664 Added 2.54%	9,051,769 Common Stock
Apr 08 2021	BUY Open market or private purchase	$2,466,000 $8.22 p/Share	300,000 Added 3.29%	8,816,105 Common Stock
Apr 07 2021	BUY Open market or private purchase	$1,648,000 $8.24 p/Share	200,000 Added 2.29%	8,516,105 Common Stock
Apr 05 2021	BUY Open market or private purchase	$1,888,000 $9.44 p/Share	200,000 Added 2.35%	8,316,105 Common Stock
Mar 29 2021	BUY Open market or private purchase	$916,000 $11.45 p/Share	80,000 Added 0.98%	8,116,105 Common Stock
Feb 24 2021	BUY Open market or private purchase	$861,000 $11.48 p/Share	75,000 Added 0.92%	8,036,105 Common Stock
Feb 23 2021	BUY Open market or private purchase	$2,653,195 $11.29 p/Share	235,004 Added 2.87%	7,961,105 Common Stock
Feb 18 2021	BUY Open market or private purchase	$14,999,990 $12.65 p/Share	1,185,770 Added 13.31%	7,726,101 Common Stock
Feb 01 2021	BUY Open market or private purchase	$935,200 $11.69 p/Share	80,000 Added 1.21%	6,540,331 Common Stock
Jan 29 2021	BUY Open market or private purchase	$955,200 $11.94 p/Share	80,000 Added 1.22%	6,460,331 Common Stock

Also insider at

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

RDUS

Radius Health, Inc. Healthcare

> 10% Shareholder

MGNX

MACROGENICS INC Healthcare

> 10% Shareholder

TNV